HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biologic behavior of resected BRCA-mutated pancreatic cancer: Comparison with sporadic pancreatic cancer and other BRCA-related cancers.

AbstractBACKGROUND:
Since margin-negative resection is essential for the cure of pancreatic cancer (PC), early detection of PC is important. Although PC is the third most common cancer associated with BRCA1/2 mutations, clinical research regarding BRCA mutations in resected PC are rare. In this study, we investigated the oncologic characteristics of resected PC with BRCA mutation to suggest management strategies.
METHODS:
We retrospectively reviewed data from 493 patients who were confirmed to be pathogenic BRCA1/2 mutation carriers between January 2007 and December 2019. We investigated the oncologic characteristics of PC patients by comparing them with resected sporadic PC and other BRCA-related cancer groups (breast cancer, ovarian cancer, and others).
RESULTS:
Ten BRCA mutation carriers (2.0%) experienced PC, and PC onset was significantly later than that of BRCA-related breast cancer (age: breast vs. pancreas, 45.0 vs. 53.5 years, p = 0.050). Six patients underwent pancreatectomy and their long-term survival outcomes did not differ from those of sporadic PC patients (disease free survival: BRCA1/2 vs. sporadic, 10.0 months vs. 9.0 months, p = 0.504; overall survival: BRCA1/2 vs. sporadic, 29.0 months vs. 35.0 months, p = 0.520).
CONCLUSION:
BRCA-mutated PC occurs later than BRCA-mutated breast cancer. Active genetic testing to identify BRCA1/2 mutation carriers at the onset of breast cancer and continuous long-term surveillance of these patients can provide opportunities to detect BRCA-mutated PC at a resectable stage.
AuthorsSung Hyun Kim, Ho Kyoung Hwang, Woo Jung Lee, Chang Moo Kang
JournalPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] (Pancreatology) Vol. 21 Issue 3 Pg. 544-549 (Apr 2021) ISSN: 1424-3911 [Electronic] Switzerland
PMID33612442 (Publication Type: Journal Article)
CopyrightCopyright © 2021 IAP and EPC. Published by Elsevier B.V. All rights reserved.
Chemical References
  • BRCA1 Protein
  • BRCA1 protein, human
  • BRCA2 Protein
  • BRCA2 protein, human
  • Biomarkers, Tumor
Topics
  • Adult
  • Aged
  • BRCA1 Protein (genetics)
  • BRCA2 Protein (genetics)
  • Biomarkers, Tumor (genetics)
  • Breast Neoplasms (diagnosis, genetics)
  • Case-Control Studies
  • Early Detection of Cancer (methods)
  • Female
  • Follow-Up Studies
  • Genetic Testing
  • Humans
  • Male
  • Middle Aged
  • Ovarian Neoplasms (diagnosis, genetics)
  • Pancreatectomy
  • Pancreatic Neoplasms (diagnosis, genetics, mortality, surgery)
  • Retrospective Studies
  • Survival Analysis
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: